Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of medical testing solutions specialist Quidel
So what: This is a one-two combination: Quidel reported analyst-crushing third-quarter revenues with an adequately small net loss and also announced FDA clearance to sell a new line of fluorescent flu-virus detectors.
Now what: The Sofia flu tester was approved for European sales in August, so production lines are already rolling. Fellow diagnostic-equipment expert Alere
Interested in more info about Quidel? Add it to My Watchlist.